Chemistry:RTI-121

From HandWiki
Short description: Chemical compound
RTI-121
Phenyltropane 25a.svg
Legal status
Legal status
  • In general: unscheduled
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H24INO2
Molar mass413.299 g·mol−1
3D model (JSmol)
  (verify)

(–)-2β-Carboisopropoxy-3β-(4-iodophenyl)tropane (RTI-4229-121, IPCIT) is a stimulant drug used in scientific research, which was developed in the early 1990s.[1] RTI-121 is a phenyltropane based, highly selective dopamine reuptake inhibitor[2] and is derived from methylecgonidine. RTI-121 is a potent and long-lasting stimulant, producing stimulant effects for more than 10 hours after a single dose in mice[3] which would limit its potential uses in humans, as it might have significant abuse potential if used outside a medical setting. However RTI-121 occupies the dopamine transporter more slowly than cocaine, and so might have lower abuse potential than cocaine itself.[4]

Uses

RTI-121 is mainly used in scientific research into the dopamine reuptake transporter. It is more selective for the dopamine transporter than other DAT radioligands such as β-CIT, and so has less nonspecific binding and produces "cleaner" images.[5][6] Various radiolabelled forms of RTI-121 (with different radioactive isotopes of iodine used depending on the application) are used in both humans and animals to map the distribution of dopamine transporters in the brain.[7][8]

Legal status

RTI-121 not specified as controlled substance in any country as of 2007. Some jurisdictions such as the United States, Australia, and New Zealand, however, might however consider RTI-121 to be a controlled substance analogue of cocaine on the grounds of its related chemical structure.

See also

References

  1. "Dopamine transporter imaging with novel, selective cocaine analogs". NeuroReport 3 (11): 969–72. November 1992. doi:10.1097/00001756-199211000-00005. PMID 1482766. 
  2. "Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester". Molecular Pharmacology 47 (4): 779–86. April 1995. PMID 7723739. 
  3. "Highly potent cocaine analogs cause long-lasting increases in locomotor activity". European Journal of Pharmacology 311 (2–3): 109–14. September 1996. doi:10.1016/0014-2999(96)00423-2. PMID 8891589. 
  4. "Rate of binding of various inhibitors at the dopamine transporter in vivo". Psychopharmacology 119 (4): 376–84. June 1995. doi:10.1007/BF02245852. PMID 7480516. https://zenodo.org/record/1232524. 
  5. "Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates". European Journal of Nuclear Medicine 22 (1): 4–11. January 1995. doi:10.1007/BF00997241. PMID 7698153. 
  6. "[123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primates". Nuclear Medicine and Biology 27 (1): 13–21. January 2000. doi:10.1016/s0969-8051(99)00083-9. PMID 10755641. 
  7. "Characterization of [125I]RTI-121 binding to dopamine transporter in vitro". Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica 18 (2): 115–20. March 1997. PMID 10072960. 
  8. "Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121)". Nuclear Medicine and Biology 23 (3): 277–84. April 1996. doi:10.1016/0969-8051(95)02074-8. PMID 8782237.